SLC34A2 and non-small cell lung carcinoma: A recent study showed that SLC34A2 (hazard ratio: 0.86, P = 0.03, coefficient = -0.1551) could be a potential prognostic immune-related gene by validating the characteristics of immune infiltration analysis in patients with NSCLC and its correlation with survival outcomes (27).